ÖZGEÇMİŞ VE ESERLER LİSTESİ ÖZGEÇMİŞ 1.1 Adı Soyadı: NAZIM SERDAR TURHAL 1.2 Doğum Tarihi: 05 NİSAN 1964 1.3. Öğrenim Durumu: Derece Bölüm/Program Üniversite Yıl Tıp Doktoru Cerrahpaşa Tıp Fakültesi İstanbul Üniversitesi 1987 Tıpta Uzmanlık Griffin Hastanesi İç Hastalıkları Ana Bilim Dalı Yale Üniversitesi 1993 Tıbbi Onkoloji Uzmanlığı Mount Sinai Tıp Fakültesi Hematoloji Onkoloji Bilim Dalı Mount Sinai Tıp Fakültesi, New York, New York, ABD 1997 1.3.1 Lisans: 1.4. Görevler: Görev Unvanı Görev Yeri Yıl Uzm. Dr. Yrd. Doç. Dr. Doç. Dr. Prof. Dr. Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı 1997-1998 1998-1999 1999-2006 2006-1.5. Aldığı Ödüller : 1.5.1 American Colloege of Physicians Certificate of Merit Mayıs 1993 Connecticut, USA 1.5.2 SOMPS 2001, Best poster/presentation award. Outcome of patients after adjuvant treatment for breast cancer. Atalay G, Turhal NS. 11 th International Congress on Anti-Cancer Treatment (ICACT), February 6-9, 2001, Paris, France 1.5.3 Atasoy BM, Abacıoğlu U, Özgen Z, Dane F, Yumuk F, Mayadağlı A, Turhal NS, Şengöz M, Rektum Kanserinin adjuvan tedavisinde radyoterapiyle eş zamanlı Tegafur-Urasil (UFT)/Folinik asit (FA) uygulanması: Tolerabilite Değerlendirilmesi, 1. Tıbbi Onkoloji Kongresi, Bildiri Özet Kitabı, SB46 (Sözlü Sunum), Antalya, 29 Mart - 2 Nisan 2006. [Sözlü Sunum Ödülü] 1
1.5.4 Dane F, Gümüş M, Öztürk MA, Atasoy BM, İyikesici S, Yumuk PF, Başaran G, Abacıoğlu U, Çabuk DÖ, Teomete M, Turhal NS, Rektum Kanseri Olgularının Klinik Özellikleri ve Adjuvan Kemoradyoterapi Sonuçları: Tek Merkez Tecrübesi, 2.Tıbbi Onkoloji Kongresi, Bildiri Özet Kitabı, P23, Antalya, 2008. [Poster Bildiri Ödülü] 1.5.5 Dane F, Gümüş M, Yaman E, Öztürk MA, Sevinç A, Atasoy BM, Çabuk D, İyikesici S, Yumuk PF, Başaran GA, Abacıoğlu U, Teomete M, Turhal NS. Küratif olarak rezeke edilmiş evre II-III rektum kanserli Türk hasta popülasyonunun adjuvan kemoradyoterapi sonuçları, prognostik özellikleri ve sağkalım analizleri, çok merkezli retrospektif çalışma. Marmara Üniversitesi Tıp Fakültesi 4. Araştırma Günleri, Marmara Medical Journal, 22(1, Ek 1), 9, İstanbul, 2009, [En İyi Bildiri Ödülü]. 1.5.6 Basaran G, Cabuk D, Korkmaz T, Kocar M, Telli F, Dane F, Yumuk F, Turhal NS.Clinical, pathological factors predicting early relapse in hormone receptor early breast cancer. BUON Congress 2010, Best Abstracts Presented at BUON Congress 2010, 8-11 September 2010, Sibiu, Romania 1.5.7 Ozturk MA, Dane F, Karagoz S, Tural D, Demirelli F, Basaran G, Buyukunal E, Mandel NM, Erdamar S, Turna H, Seber S, Turhal NS, Serdengecti S. The prognostic value of perineural invasion in patients with early stage colon cancer. BUON Congress 2010, Best Abstracts Presented at BUON Congress 2010, Proceedings Book, 8-11 September 2010, Sibiu, Romania. BA 65, page 23 1.6. Aldığı Burslar: European School of Medical Oncology Technology Transfer Grant 2000 2
1.7. Üyesi Olduğu Meslek Kuruluşları: Türk Tabipler Birliği 1997 Türk Onkoloji Grubu 1997 Türk Onkoloji Derneği 1997 American College of Physicians 1998 Balkan Union of Oncology 1998 European Society of Medical Oncology 1999 American Society of Clinical Oncology 1999 1.8. Yeterlilik Kurulu Üyeliği: Türk Onkoloji Derneği 2007 3
1.8. Lisans ve Lisans üstü eğitimde verdiği dersler: Akademik Yıl Dönem Dersin Adı Teorik Haftalık Saati Uygulama Öğrenci Sayısı Güz Marmara Üniversitesi Tıp Fakültesi Dönem 4 İç Hastalıkları Stajı Marmara Üniversitesi Tıp Fakültesi Dönem 6 İç Hastalıkları Stajı Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Eğitim Programı Marmara Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Yan Dal Uzmanlığı Eğitim Programı 2 4 55 2 10 4 2 10 4 2-34 2 10 3 2002-2003 Marmara Üniversitesi Tıp Fakültesi Dönem 4 İç Hastalıkları Stajı Marmara Üniversitesi Tıp Fakültesi Dönem 6 İç Hastalıkları Stajı Tıbbi Onkoloji Rotasyonu (birer ay) 2 4 55 2 10 4 İlkbahar Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Eğitim Programı Marmara Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Yan Dal Uzmanlığı Eğitim Programı Marmara Üniversitesi Tıp Fakültesi Dönem 4 İç Hastalıkları Stajı 2 10 4 1-34 2 10 3 2 4 55 4
Güz Marmara Üniversitesi Tıp Fakültesi Dönem 6 İç Hastalıkları Stajı Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Eğitim Programı Marmara Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Yan Dal Uzmanlığı Eğitim Programı 2 10 4 2 10 4 2-34 2 10 3 2003-2007 Marmara Üniversitesi Tıp Fakültesi Dönem 4 İç Hastalıkları Stajı Marmara Üniversitesi Tıp Fakültesi Dönem 6 İç Hastalıkları Stajı Tıbbi Onkoloji Rotasyonu (birer ay) 2 4 55 2 10 4 İlkbahar Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Tıbbi Onkoloji Rotasyonu (birer ay) Marmara Üniversitesi Tıp Fakültesi Tıpta Uzmanlık Öğrencileri Eğitim Programı Marmara Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Yan Dal Uzmanlığı Eğitim Programı 2 10 4 1-34 2 10 3 5
1.9. Yönettiği tamamlanmış tezler: 1- Primer meme kanserinin saptanmasında teknezyum 99m-metilendifosfonat mamosintigrafisinin in vivo kullanımı Dr. Faysal Dane, İstanbul 2002 2- Meme kanserli hastalarda normal ve tümöral doku örneklerinde human papilloma virüs(hpv) DNA sıklığı ve HPV tip tayini Dr. Mahmut Gümüş, İstanbul 2003 3- Evre II III kolorektal kanserlerde timidilat sentetaz ve COX-2 nin prognostik faktör olarak incelenmesi. Uzm. Dr. Mehmet Aliustaoğlu, İstanbul 2003 4- Mide kanserinde bağışıklık yanıtının anjiogenezin ve sekonder lenfoid doku kemokin ekspresyonunun değerlendirilmesi Dr. Meltem Ekenel, İstanbul 2005 5- Mide kanserinde HIF-1 Alfa, Vegf ekspresyonu ve bu faktörlelrin prognostik önemi. Dr. Devrim Özcan Çabuk, İstanbul 2006 6- Unrezektabl evre III ve evre IV küçük hücreli dışı akciğer kanseri tanılı kadın hastaların klinik özellikleri ve sağkalım analizleri Uzm Dr Mehmet Teomete, İstanbul 2008 1.11. Yönetim Hizmetleri: Onkoloji Bilim Dalı Başkanı 1997-1.12. Üniversite içinde ve / veya dışında eğitim, öğretim, araştırma, geliştirme, üretim alanlarında yöneticilik veya kuruculuk yapmış olmak: 1. Avrupa Kanser Araştırma Birliği Mide Kanseri Araştırma Kurulu Kurucu Üyesi 2. BİKİMER Marmara Üniversitesi Bilimsel Araştırma Komisyonu Kanser Araştırma Grubu Kurucu Üyesi 1.13. Hakemlik veya yayın danışma kurulu üyeliği: 1.13.1. Makale hakemliği 1. Türkiye Klinikleri Tıp Bilimleri Dergisi 2. Kartal Eğitim Araştırma Hastanesi Tıp Dergisi 3. Turkish Journal of Cancer 4. International Journal of Experimental and Clinical Chemotherapy 5. Biomed Central, Cancer 1.13.2. Yayın kurulu üyeliği 1. Turkish Journal of Cancer 6
2. ACTA Oncologica Turkish Edition 3. Kartal Eğitim Araştırma Hastanesi Tıp Dergisi 4. Türkiye Klinikleri Tıp Bilimleri Dergisi 5. British Journal of Cancer 7
2. BİLİMSEL ÇALIŞMALAR: 2.1. Doktora veya İhtisas Tezi: Mide Kanseri için yeni peri adjuvan tedavi stratejileri. Tez Danışmanı: Prof. Dr. Howard Bruckner, Mount Sinai Tıp Fakültesi İleri safha pankreas kanserinde kombine tedavi uygulaması ve uzun dönemli takibi. Tez Danışmanı: Prof. Dr. Howard Bruckner, Mount Sinai Tıp Fakültesi 2.2. Doktora veya ihtisas tezinden yayınlanmış makaleler: A. DOÇENTLİK ÖNCESİ 2.2.1. Turhal NS, Bruckner HW. New neoadjuvant treatment strategies for gastric and gastroesophageal junction cancers, Marmara Medical Journal 1999 12(1): 20-24. 2.2.2. Turhal NS, Terk M, Bruckner HW. Combined Modality Therapy for Pancreatic Cancer. Turkish Journal of Cancer, 1999 11(2): 55-64. 2.3. Doktora veya ihtisas tezi dışında yayınlanmış makaleler: 2.3.1. Uluslararası hakemli dergilerde yayımlanan makaleler : A. DOÇENTLİK ÖNCESİ 2.3.1.1. Turhal N, Sullivan MB, Blakemore WS. Thyroglossal Duct Cyst. South Med J, 1990, 83:8, 983-4. Atıflar: 2 adet 2.3.1.2. Turhal N, DeLuca VA Jr. Ulcerative Colitis and Scleroderma. A coincidental relationship. J Clin Gastroenterol. 1994, 18:3, 218-9. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=14087877503050283226 2.3.1.3. Turhal NS, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol 1998, 57:1, 51-56. Atıflar: 5 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=16038244302575248353 2.3.1.4. Turhal NS. Cyclosporin A and Imipenem Associated Seizure Activity in Allogeneic Bone Marrow Transplantation Patients. Journal of Chemotherapy 1999 11(5): 410-413. Atıflar: 1 adet 8
B. DOÇENTLİK SONRASI 2.3.1.5. Turhal NS, Erdal S, Karacay S. Efficacy of the Treatment to Relieve Mucositis Induced Discomfort. Supportive Care in Cancer 2000 8(1): 55-58. Atıflar: 11 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=9224762740491128396 2.3.1.6. Turhal NS. Pancreatic Duct Cell Carcinoma with Positive In-111 Octreotide Uptake. Journal of Experimental and Clinical Cancer Research 2000 19(2): 241-244. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3086857171421125646 2.3.1.7. Turhal NS. Sumatriptan overdose in episodic cluster headache: a case report of overuse without event. Cephalalgia. 2001 21:700. Atıflar: 2 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3305478064832093771 2.3.1.8. Turhal NS, Rand J. Antiphospholipid syndrome in HIV infection - Report of four cases and review of literature. Allergy & Clinical Immunology International 2001 13(6):1-4. Atıflar: 4 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7397992836540309533 2.3.1.9. Duman D, Turhal NS, Duman DG, M.D. Fatal Aplastic Anemia during Treatment with Ketoconazole. American Journal of Medicine 2001, 111:9 Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3117564245376579991 2.3.1.10. Turhal NS. Two cases of advanced renal cell cancer with prolonged survival of 8 and 12 years. Japanese Journal of Clinical Oncology 2002 32(4): 152-153 Atıflar: 1 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=13935624351722493486 2.3.1.11. Turhal NS, Gumus M, Atalay G, Aliustaoglu M, Kabakas F, Karamanoglu A, Sengoz M. Outpatient cancer care in a Turkish university hospital. Journal of BUON 2002 7(4): 397-398. 2.3.1.12. Turhal NS, Efe B, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M. Patient satisfaction in the outpatients` chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey. BMC Cancer 2002 2(1): 30-33. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10755444610255035949 2.3.1.13. Turhal NS, Aliustaoglu M, Gurses I, Gumus M, Atalay G, Karamanoglu A, Sengoz M. Neoplastic diseases prevalence in a Turkish university hospital. Journal of BUON 2003 8(1): 45-48. 2.3.1.14. Karamanoglu A, Yumuk PF, Gumus M, Aliustaoglu M, Selimen D, Sengoz M, Turhal NS. Port needles: Do they need to be removed as frequently in infusional chemotherapy? Journal of Infusional Nursing 2003 26(4):239-242. 9
Atıflar: 3 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3285498604753279414 2.3.1.15. Abacıoglu U, Sengoz M, Yumuk F, Salepci T, Turhal NS. Cisplatin and etoposide in extra pulmonary small cell cancer. Tumori 2003 89(3): 274-277. Atıflar: 20 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12670133082976671960 2.3.1.16. Yumuk PF, Abacioglu U, Caglar H, Gumus M, Sengoz M, Turhal NS. Outcome of rectum and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital. J Chemother 15 (6): 603-606, 2003. 2.3.1.17. Turhal NS, Dane F, Dede F, Gumus M, Yumuk PF, Cakalagaoglu F, Savcı D, Karaman M, Gulluoglu B, Turoglu HT. 99m-Tc-MDP Scintimammography to assess angiogenesis in patients with untreated breast cancer. Anticancer Research. 24:1999-2006 (2004) Atıflar: 1 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=8066682829616811384 2.3.1.18. Yumuk PF, Gumus M, Ekenel M, Basaran G, Aliustaoglu M, Topal A, Turhal NS, N. Attitude Toward Genetic Testing in Turkish Society. Genetic Testing 8(2):169-173, 2004 Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12681732269582698398 2.3.1.19. Yumuk PF, Aydin SZ, Dane F, Gumus M, Ekenel M, Aliustaoglu M, Karamanoglu A, Sengoz M, Turhal NS. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients. International Journal of Colorectal Disease 19: 609-610, 2004. Atıflar: 1 Adet 2.3.1.20. Bolukbas FF, Kılıc H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavalı B. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004, 4:29-32. Atıflar: 7 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=17826764500982860129 2.3.1.21. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS. Does the Incidence of Anal Canal Cancers Differ in Moslem Societies? International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery. 20(1), 76 2004. 2.3.1.22. Aliustaoglu M, Yumuk PF,Gumus M, Ekenel M, Bolukbas F, Mutlu N, Basaran G, Avsar E, Turhal NS. D-Dimer Can it be a marker for malignant gastric lesions. Acta Oncologica, 2004 Dec 43(8) 770-771. Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10828204231987902171 2.3.1.23. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D Haese S, Coens C. Clinical and 10
Psychometric validation of a questionnaire module, The EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer, 2004 Oct 40(15): 2260-8 Atıflar: 13 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7446152185685022904 2.3.1.24. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar H, Sengoz M, Turhal S. What should be the optimal number of lymph nodes dissected in colorectal Cancer surgery? Tumori, 172/03. 11 2004. PROFESÖRLÜK SONRASI 2.3.1.25. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R, Results of paclitaxel (day 1 and 8) and Carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung Cancer, BMC Cancer, (MS:7372801141679098), 2005 March, 21 2.3.1.26. Abacioğlu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, Concurrent chemoradiotherapy with low dose weekly Gemcitabine in stage III non-small cell lung cancer. BMC Cancer. 2005 Jul, 6;5:71 Atıflar: 3 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=4020091328951835599 2.3.1.27. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R. Results of Paclitaxel (day 1 and 8) and carboplatingiven on every three weeks in advanced (stage III-IV) non-small cell lung cancer. BMC Cancer. 2005 Jan 25;5:10. 2.3.1.28. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS, Does the incidence of anal canal cancers differ in Moslem societes? International Journal of Colorectal Disease 2005 20:76 2.3.1.29. Turhal NS, Popov I. Colorectal cancer care in the Balkan countries. Journal of Balkan Union of Oncology Volume 10 No: 2, April-June 2005 189-193 2.3.1.30. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar H, Sengoz M, Turhal NS, What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005 Mar-Apr;91(2): 168-72 Atıflar: 5 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10239756734860738799 2.3.1.31. Abacioglu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. BMC Cancer, 2005 Jul 6;5:71 2.3.1.32. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Eur Urol. 2006 Feb; 49(2):7. Epub 2005 Nov 7. Atıflar: 2 Adet 11
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=5503029184430428787 2.3.1.33. Turhal NS, Popov IP. Colorectal cancer care in the Balkan countries. J BUON 2005 Apr-Jun;10(2):189-93 2.3.1.34. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention: Part 2. Eur Urol 2006 Mar 49(3):578-80. 2.3.1.35 Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients normal and tumoral tissue samples. J Exp Clin Cancer Res. 2006 Dec;25(4):515-21. 2.3.1.36. Onol FF, Tandr Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Part 1: Eur Urol 2006 Feb;49(2): 406-7 2.3.1.37. Onol FF, Tandr Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Part 2: Eur Urol. 2006 Mar; 49(3):578-80. 2.3.1.38. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients normal and tumoral tissue samples. Journal of Experimental and Clinical Cancer Research, December 2006, 515-521 Atıflar: 7 Adet 2.3.1.39. Komurcu S, Turhal NS, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altinbas M, Pak Y, Cooper R, Yaylaci M, Demirkan B, Sarihan S, Ozdemir F. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish Oncology group trial. Eur J Cancer Care (Engl). 2007 Jan; 16(1):67-73 2.3.1.40. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal NS, Sengoz M. Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. J BUON. 2007 Apr-Jun;12(2):203-8. Atıflar: 1 Adet 2.3.1.41. Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal NS. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res. 2007:13(3):215-26. Epub 2007 Oct 7. 2.3.1.42. Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M, Turhal NS. Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and 12
CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival. Oncology. 2007 Nov 15;72(1-2):111-117. Atıflar: 1 Adet 2.3.1.43. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal NS, Sengoz M. Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. Journal of BUON 12: 203-208, 2007 2.3.1.44. Yumuk PF, Dane F, Yumuk VD, Yazici D, Ege B, Bekiroglu N, Toprak A, Iyikesici S, Basaran G, Turhal NS.Impact of body mass index on cancer development. J BUON. 2008 Jan-Mar;13(1):55-59 2.3.1.45. Atasoy BM, Dane F, Yumuk PF, Akgün Z, Turhal NS, Abacioğlu U, Sengöz M. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON. 2008 Jan-Mar;13(1):43-50. 2.3.1.46. Koldas M, Gumus M, Seker M, Seval H, Huyla K, Dane F, Kural A, Gumus A, Salepci T. and NS Turhal, Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer, Clin Lung Cancer., 9(2), 112-115 (2008). 2.3.1.47. Ustaalioglu BB, Gumus M, Bilici A, Seker M, Dane F, Salepci T, S alman T, Aliustaoglu M, Gezen C, Yaylaci M, Turhal NS, Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience. Med. Oncol, 2009 Jun 2. 2.3.1.48. Kefeli U, Dane F, Yumu k PF, Karamanoglu A, Iyikesici M, Basaran G, Turhal NS, Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. Eur J Cancer Care (Engl), 2009 Mar; 18(2), 191-4. 2.3.1.49. Kuscu MK, Dural U, Onen P, Yasa Y, Yayla M, Basaran G, Turhal NS, Bekiroglu N. The association between individual attachment patterns, the perceived social support, and the psychological well-being of Turkish informal caregivers. Psychooncology, 2009 Jan 12. 2.3.1.50. Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, Turhal NS. A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin s lymphoma: The importance of second opinion. J BUON, 2009 Apr-Jun;14(2):309-11. 2.3.1.51. Kefeli U, Dane F., Yumuk PF, Karamanoglu A, Iyikesici S, Basaran G, and NS Turhal, Prolonged inerval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer, Eur J Cancer Care (Engl), 18(2), 191-194 (2009). 2.3.1.52. Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, and NS Turhal, A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin s lymphoma: the importance of second opinion, J BUON, (2009). [basımda] 2.3.1.53. Gumus M, Basak O, Ustaalioglu MG, Kiziltan E, Bilici A, Seker M, Erkol B, Salepci T, Mayadagli A, Turhal NS. Factors that Affect Patients Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients. Breast Care 2010;5:164 168 13
2.3.1.54. Dane F, Yumuk PF, Başaran G, Gündüz F, Peker Ö, Turhal NS, A Case of Primary Breast Mantle Cell Lymphoma with Atypical Relapse Patterns and Rewiew of the Literature Journal of BUON Vol: 16 No: 2, 2010 2.3.1.55. Turhal NS, Bas E, Er O, Aliustaoglu M, Seber S, Dane F, Korkmaz T, Soyuer I, Ozkara S, Celikel C. ERCC1 is not expressed in hepatocellular cancer: A Turkish Oncology Group, Gastrointestinal Oncology Subgroup study. Journal of BUON 15: 794-796, 2010 2.3.1.56. Turhal NS. Dane F, Sınav H, Yalçın N, Khorshidi Z, Yalçın ZZ. Anxiety and depression in Turkish breast cancer patients. Journal of BUON 15: 720-725, 2010 2.3.1.57. Korkmaz T, Seber S, Turhal NS. Primary melanoma of the gallbladder. Letter 802 2.3.1.58. Basaran G, Cabuk D, Caglar HB, Gulluoglu B, Kaya H, Seber S, Korkmaz T, Telli F, Kocak M, Dane F, Yumuk PF, Turhal NS. Clinical outcome of breast cancer patients with N3a ( 10 positive lymph nodes) disease: has it changed over years? Med Oncol. 2010 Apr 14. [Epub ahead of print] DOI 10.1007/s12032-010-9516-1. 2.3.1.59. Dane F, Ozturk MA, Gumus M, Guven A, Aliustaoğlu M, Cabuk D, Teomete M, Basaran G, Yumuk PF, Turhal NS. Effi cacy, safety and prognostic features of resected colon carcinoma treated in real world practice: a retrospective cohort-study. Journal of BUON 16: 257-264, 2011 2.3.1.60. Bilici A, Dane F, Seker M, Ustaalioglu BB, Aliustaoglu M, Temiz S, Gezen C, Yavuzer D, Aksu G, Mayadagli A, Gumus M, Uygun K, Turhal NS. Is Subdivision of pt2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers. Digestive Diseases And Scienses DOI: 10.1007/s10620-011-1721-z 2011. 2.3.1.61. Dane F, Akif Ozturk M, Gumus M, Guven A, Aliustaoglu M, Cabuk D, Teomete M, Basaran G, Fulden Yumuk P, Turhal NS. Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study. J BUON. 2011 Apr-Jun;16(2):257-64. 2.3.1.62. Basaran G, Devrim C, Caglar HB, Gulluoglu B, Kaya H,Seber S, Korkmaz T, Telli, Kocar M, Dane F, Turhal NS. Clinical outcome of breast cancer patients with N3a ( 10 positive lymph nodes) disease: has it changed over years? Medical Oncology: Volume 28, Issue 3 (2011), Page 726-732. 2.3.1.63. Korkmaz T, Seber S, Basaran G, Yumuk PF, Dane F, Kocar M, Telli F, Turhal NS. 5-Flourouracil Induced Encephalopathy in Parkinson s disease. International Journal of Hematology and Oncology 2011 vol: 21 Num 1 Page(s): 001-003 2.3.1.64. Abali H, Ata A, Ozdogan M, Turhal NS, Cabuk D, Seyrek E, Coskun HS, Arik Z, Erman M, Celik I. Frequency of comorbid illnesses in cancer patients in Turkey. Journal of BUON 16: 557-560, 2011. 2.3.1.65. Turhal NS, Dane F, Butur S, Kocak M, Telli F, Seber S, Kanitez M, Aktas B, Yumuk PF. Efforts to Validate the Applicability of Established Chemotherapy Treatment in Turkish Cancer Patient. Pharmaceutica Analytica Acta. S14. 2011 2.3.1.66. Okutur K, Korkmaz T, Seber S, Dane F, İlhan M, Turnal NS, Demir G. Weekly Docetaxel, Cisplatin and 5-Flourouracil in the first-line treatment of metastatic gastric cancer. MOJ:1;35-40, 2011. 14
2.3.1.67. Turhal NS. Daily life of a Turkish Medical Oncologist. J Oncol Pract 8:164-166, 2012 2.3.1.68. Korkmaz T, Seber S, Okutur K, Basaran G, Yumuk F, Dane F, Oney T, Polat O, Madenci O, Demir G, Turhal NS. Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer. Biomarkers, 2012; Early Online: 1 7 2012 Informa UK, Ltd. 2.3.1.69. Turhal NS et al. The Association between Socio-Demographic Parameters and the Use of Complementary Interventions in Cancer Patients in Turkey A Turkish Oncology Group Study. Journal of Cancer Therapeutics and Research, ISSN: 2049-7962, Volume: 1, Issue: 1, 2012 2.3.1.70. Uncu D, Aksoy S, Cetin B, Yetisyigit T, Ozdemir N, Berk V, Dane F, İnal A, Harputluoglu H, Budakoglu B, Koca D, Sevinc A, Cihan Ş, Durnalı AG, Ozkan M, Oztürk M, Işıkdoğan A, Büyükberber S, Benekli M, Köş T, Alkış N, Karaca H, Turhal NS, Zengin N. Anatolian Society of Medical Oncology. Results of Adjuvant FOLFOX regimens in stage III. Colorectal Cancer Patients. Retrospective Analysis of 667 Patients. Oncology 2013.84:240 245 2.3.1.71. Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. Primary renal carcinoid: Treatment and prognosis. Critical Reviews in Oncology/Hematology-2013 ONCH-1712; No of pages 19. 2.3.1.72. Artac M, Turhal NS, Kocer M, Karabulut B, Bozcuk H, Yalcin S, Karaagac M, Gunduz S, Isik N, Uygun K. Do high-risk features support the, use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. Tumori, 100:143-148, 2014 2.3.1.73. Kani HT, Siykhmbayev A, Demircan N, Banzragch M, Gunes Yegin E, Bicakci Y, Aydin Y, Irmak R, Guney Duman D, Yumuk PF, Dane F, Turhal NS, Bekiroglu N, Ozdogan OC. Benefıcıal Effect of Multıdıscıplınary approach on Survıval ın Hepatocellular Carcınoma Patıents. Journal of Hepatology2014 vol 60. S215-S359, P577 2.3.1.74. Kocar M, Bozkurtlar E, Telli F, Turhal NS, Kaya H, Kocar H, Yumuk PF. PTEN loss is not associated with trastuzumab resistance in metastatic breast cancer. JBUON 2014; 19(4): 900-905. 2.3.1.75. Yalcin S, Trad D, Yasser AK, Halawani H, Demir OG, Mall R, Meshcheryakov A, Nasr F, Nosworthy A, Osinsky D, Tumanova A, Turhal NS, Tejpar S, Köhne CH. Personalized treatment is beter than one treatment fits all in the management of patients with mcrc: a consensus statement. Future Oncol 2014; 10(16), 2643-2657 2.3.1.76. Tanriverdi O, Yavuzsen T, Akman T, Senler FC, Taskoylu BY, Turhal NS, Komurcu S, Cehreli R, Yaren A, Ozyilkan JCED: Your manuscript entitled The perspective of non-oncologistphysicians on patients with metastatic cancer and palliative care (ALONEStudy): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2015 Jun;30(2):253-9. doi: 10.1007/s13187-015- 0794-3. PMID: 25631655 [PubMed - in process] 2.3.1.77 Dede F, Civen H, Dane F, Aliustaoglu M, Turhal NS, Turoglu HT, İnanir S. Carbon-14 urea breath test: does it work in patients with partial gastric resection? Ann Nucl Med. 2015 Nov;29(9):786-91. doi: 10.1007/s12149-015-1005-3. Epub 2015 Jul 18. PMID: 26187581 [PubMed - in process] 2.3.1.78. Ozturk MA, Dane F, Karagoz S, Tural D, Selcukbiricik F, Demirelli F, Buyukunal E, Ozguroglu M, Turna H, Erdamar S, Celikel CA, Bozkurtlar EB, Yumuk PF, Mandel NM, Turhal NS, Serdengecti S. Is perineural invasion (PN) a determinant of disease free 15
survival in early stage colorectal cancer? Hepatogastroenterology. 2015 Jan- Feb;62(137):59-64. PMID: 25911868 [PubMed - indexed for MEDLINE] 2.3.1.79. Ozturk MA, Dane F, Karagoz S, Tural D, Selcukbiricik F, Demirelli F, Buyukunal E, Ozguroglu M, Turna H, Erdamar S, Celikel CA, Bozkurtlar EB, Yumuk PF, Mandel NM, Turhal NS, Serdengecti S. Epidemiology of colorectal cancer in Turkey: A crosssectional disease registry study (A Turkish Oncology Group trial). Turk J Gastroenterol. 2015 Mar;26(2):145-53. doi: 10.5152/tjg.2015.5685. PMID: 25835113 [PubMed - indexed for MEDLINE] 2.3.1.80. Tanriverdi O, Yavuzsen T, Turhal NS, Kilic D, Yalcin S, Ozkan A, Uzunoglu S, Uysal- Sonmez O, Akman T, Aktas B, Ulger S, Babacan T, Komurcu S, Yaren A, Cay-Senler F. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Eur J Cancer Care (Engl). 2015 Mar 30. doi: 10.1111/ecc.12315. [Epub ahead of print] PMID: 25828949 [PubMed - as supplied by publisher] 2.3.1.81. Tanriverdi O, Cay-Senler F, Yavuzsen T, Turhal NS, Akman T, Komurcu S, Cehreli R, Ozyilkan O. Perspectives and practical applications of medical oncologists on defensive medicine (SYSIPHUS study): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Med Oncol. 2015 Apr;32(4):106. doi: 10.1007/s12032-015-0555-5. Epub 2015 Mar 7. PMID: 25750041 [PubMed - in process] 2.3.2. Ulusal hakemli dergilerde yayımlanan makaleler : A. DOÇENTLİK ÖNCESİ 2.3.2.1. Turhal NS. Metastatik meme kanseri yaygın kemik metastazlarında tedavi, Kanser Gündemi, Türkiye Kanserle Savaş Vakfı, 1998 3(3): 118-121. 2.3.2.2. Turhal NS. Yetişkin kanser hastalarında transfüzyon tedavisi yaklaşımları Damla, Kan Merkezleri ve Transfüzyon Derneği Bülteni, 1998 22:4-7. 2.3.2.3. Turhal NS. Meme kanserinin biyolojik tedavisinde: Herceptin, Academic Hospital 1998 4:16-18. 2.3.2.4. Turhal NS, Tanju P, Pekin S. Serviks kanseri etyolojisine yönelik standart ve gelecek vadeden tarama yaklaşımları Hekimler Birliği Vakfı, Türkiye Klinikleri, Jinekolojik Obstetrik, 1999 9(3): 215-220. 2.3.2.5. Turhal NS, Akdas A. Prostat kanserinde gen tedavisi uygulaması ve sorunları Üroloji Bülteni 1999 10(1): 5-11. B. DOÇENTLİK SONRASI 2.3.2.6. Turhal NS. Lokal ileri evre meme kanserinde neoadjuvan ve adjuvan 16
kemoterapi Hematoloji-Onkoloji, Güncel Derleme Dergisi, 2001 3(2):123-127. 2.3.2.7. Atalay G, Turhal NS. Kanserli hastalarda ağrı dışı semptomların palyasyonu: Hıçkırık, disfaji ve dispepsi Hematoloji-Onkoloji, Güncel Derleme Dergisi, 2001, 3(3): 236-239. 2.3.2.8. Kaya H, Kotiloglu E, Sengoz M, Turhal S, Uneri C. Aggressive fibromatosis: A case report. Journal of Marmara University Dental Faculty, 2001 Vol 4(3): 288-90. 2.3.2.9. Basaran G, Ekenel M, Demirkalem P, Cakır T, Gulluoglu B, Gumus M, Dane F, Iyikesici S, Kaya H, Yumuk PF, Turhal NS. Evre 1 (T1 N0 M0) Meme Kanseri: Patolojik özellikler ve klinik sonuçlar, Türk Onkoloji Dergisi, 2004 19(2):53-57. 2.3.2.10. Yumuk PF, İyikesici MS, Gumus M, Aliustaoglu M, Dane F, Basaran G, Ekenel M, Abacıoglu U, Turhal NS. Lokal ileri ve metastatik küçük hücreli dışı akciğer kanseri hastalarının değerlendirilmesi, Marmara Üniverstesi deneyimi, Türk Onkoloji Dergisi, 2004 19(3): 106-110. 2.3.2.11. Yumuk PF, Turhal NS. Bir medikal onkolog perspektifinden muskuloskeletal hastalıklarda nükleer tıp Turkish Journal of Nuclear Medicine 2004, Baskıda 2.3.2.12. Atasoy BM, Dane F, Sarı M, Yumuk PF, Akgün Z, Turhal NS, Abacıoğlu U, ve Şengöz M, Lokal ileri evre skuamöz hücreli baş ve boyun kanserinde sisplatinle eş zamanlı kemoradyoterapi: Yan etki ve uygulanabilirlik analizi, Türk Onkoloji Dergisi, 23, 1-11 (2008). 2.3.2.13. Atasoy BM, Dane F, Çağlar H, Tezcanlı E, Cingi A, Abacıoğlu U, Turhal NS, ve C Yeğen, Rezeke edilebilir lokal ileri evre rektum kanserinde floroprimidin bazlı kemoterapi ile eş zamanlı ameliyat öncesi radyoterapi, Türk Onkoloji Dergisi, 23, 163-171 (2008). 2.3.2.14. Atasoy BM, Dane F, Kefeli AÜ, Caglar H, Cingi A, Turhal NS, Abacıoglu U, Yegen C. Concomitant chemoradiotherapy with low-dose weekly Gemcitabine for nonmetastatic unresectable pancreatic cancer. The Turkish Journal of Gastroenterology 2011;22(1):60-64 2.3.3. Yayınlarına yapılan atıflar (citation): 2.3.3.1. Author(s): Kim JH; Lee SH; Park J; Kim HY; Lee SI; Nam EM; Park JO; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K. Title: Extrapulmonary small-cell carcinoma: a single-institution experience. Source: JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2004, Vol 34, Iss 5, pp 250-254 2.3.3.2. Yao JL, Madeb R, Bourne P, Lei J, Yang X, Tickoo S, Liu Z, Tan D, Cheng L, Hatem F, Huang J, Anthony S. Title: Small Cell Carcinoma of the Prostate: An Immunohistochemical Study. Source: American Journal of Surgical Pathology. 30(6):705-712, June 2006 2.3.3.3. Author(s): D. Demellawy, A. Samkari, M. Sur, F. Denardi, S. Alowami. Title: Primary small cell carcinoma of the cecum. Source: Annals of Diagnostic Pathology, Volume 10, Issue 3, Pages 162-165 17
2.3.3.4. Author(s): Young HK, Ryuk K, Ghap JJ, Myung HR, Sang YH, Hyuk CK, Jin SJ, Tae BS, Jong YO, Ki NL. Title: Extrapulmonary small-cell carcinoma of the liver Source: Journal of Hepato-Biliary-Pancreatic Surgery Oct. 2004 Vol 11, Num 5, 2.3.3.5. Author(s): Vogelsang H., Siewert I.R. Title: Neuroendokrine Tumors of the hindgut Source: Best Practice & Research Clinical Gastroenterology, Volume 19, Issue 5, Pages 739-751 2.3.3.6. Author(s): A. Ferlito, K. Devaney, A. Rinaldo Title: Neuroendocrine neoplasms of the larynx: Advances in identification, understanding, and management Source: Oral Oncology, Volume 42, Issue 8, Pages 770-788 2.3.3.7. Author(s): E. Kurt, C. Sezgin, T. Evrensel, U. Yalcinkaya, O. Kanat, A. Veral, M. Demiray, M. Arslan, B. Karabulut, I. Ercan, E. Goker, O. Manavoglu Title: Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma Source: International Journal of Clinical Practice; 2005; 59 (5), 537 543. 2.3.3.8. Author(s): Chen JW, Yuan L, Hu HH Title: Small cell undifferentiated carcinoma in the epididymis Source: Chinese Medical Journal 2005; 118(16): 1402-1404 2.3.3.9. Author(s): Author(s): Vogelsang H., Siewert I.R. Title: Neuroendokrine Tumoren des Kolons und Rektums, Mit Ausnahme der Appendix Source: MULTİ MODALİTY TREATMENT RESULTS Onkologe 2004-10:1069-1078 2.3.3.10. Author(s): Kim KO; Lee HY; Riyu MH; Shin SJ; Kim MK; Lee KH; Hyun MS; Bae HS; Ryoo HM. Title: Extrapulmonary small-cell carcinoma Source: J Korean Med. Sci. 2006; 21: 833-7 2.3.3.11. Author(s): Lee SS; Lee JL; Riyu HM; Chang HM; Tae WK; Jung SL; Jang SJ; Khang SK; Kang YK Title: Extrapulmonary small cell carcinoma: Single center experience with 61 patients Source: Acta Oncologica, Volume 46, Issue 6 2007, pages 846 851 2.3.3.12. Author(s): M. Yashi, F. Terauchi, A. Nukui, M. Ochi, M. Yuzawa, Y. Hara, T. Morita Title: Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: A case report and short literature review Source: Urologic Oncology: Seminars and Original Investigations, Volume 24, Issue 4, Pages 313-317 2.3.3.13. Author(s): A Barbeaux, L Duck, B Weynand, G Desuter, M Hamoir, V Gregoire, J Baurain, J Machiels Title: Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities Source: Oto-Rhino- Laryngology, 2006; Volume 263, Number 8 / 786-790 2.3.3.14. Author(s): L Kovac, M Gjuric, S Branica, K Dawidowsky, S Seiwerth Title: Small cell neuroendocrine carcinoma in the petrous apex Source: Journal of Laryngology & Otology (2006), 120: 74-76 2.3.3.15. Author(s): N. Güler, P. Yumuk, D. Ilguy, V. Olgac, J. Greer Title: Limited Painful Mouth Opening Source: Journal of Oral and Maxillofacial Surgery, Volume 63, Issue 8, Pages 1201-1205 2.3.3.16. Author(s): R. Simon, P. Bourne, Q. Yang, B. Spaulding, P. di Sant'Agnese, H. Wang, H. Xu Title: Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not Source: Human Pathology, Volume 38, Issue 8, Pages 1178-1183 2.3.3.17. Author(s): WT hsueh, WC Su, FF Chen Title: Experiences of Radiotherapy on Extrapulmonary Small Cell Carcinoma Source: 2005, 2, 24. 18
2.3.3.18. Author(s): DE Demellawy, MA Khalifa, N Ismiil, S Wong, Z Ghorab Title: Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases Source: Diagn Pathol. 2007; 2: 35. 2.3.3.19. Author(s): Yuan ZY, Guan ZZ, Zhou ZM, Xia Y, Huang WZ, Yang XL.Title: Extrapulmonary small cell carcinoma in 52 patients Source: Chinese Medical Journal 2006 Sep; 25(9): 1131-3. 2.3.3.20. Author(s): G. Lima, I. Varkarakis, M. Allaf, S. Fine, L. Kavoussi Title: Small cell carcinoma of epididymis: Multimodal therapy Source: Urology, Volume 66, Issue 2, Pages 432.e19-432.e20 2.3.3.21. Author(s): AF Korcum; G Aksu; M Ozdogan; G Erdogan; O Taskin Title: Stage I small cell carcinoma of the endometrium: survival and management options Source: Acta Obstetricia et Gynecologica Scandinavica, 200 2.3.3.22. Author(s): EB. Rubenstein, DE Peterson, M Schubert, D Keefe, D McGuire, J Epstein, LS. Elting, PC. Fox, C Cooksley, ST. Sonis,Title: Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis Source: Cancer 2004 Volume 100, Issue S9, Pages 2026 2046 2.3.3.23. Author(s): PJ Hancock, JB Epstein, GR Sadler Title: Oral and dental management related to radiation therapy for head and neck cancer Source: J Can Dent Assoc 2003, Vol 69 No: 9, 585-590 2.3.3.24. Author(s): DB. McGuire, ME Correa, J Johnson, P Wienandts, Title: The role of basic oral care and good clinical practice principles in the management of oral mucositis Source: Supportive Care in Cancer 2006, Vol 14, No 6, 541-547 2.3.3.25. Palliative Medicine Handbook 3. Dr lan Back 2001 2.3.3.26. Author(s): DJ Harris, MT Knobf, Title: Assessing and Managing Chemotherapy-Induced Mucositis Pain Source: Clinical Journal of Oncology Nursing, 2004, Vol 8, No 6, 622-628 2.3.3.27. Author(s): EMB Costa; MZ Fernandes; LB Quinderé; LB Souza; LP Pinto Title: Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia Source: Pesqui. Odontol. Bras. 2003;17(2):147-50 2.3.3.28. Author(s): D. Alterio, B. Jereczek-Fossa, G. Zuccotti, M. Leon, E. Omodeo Sale, M. Pasetti, T. Modena, P. Perugini, L. Mariani, R. Orecchia Title: Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study Source: International Journal of Radiation Oncology*Biology*Physics, Volume 64, Issue 2, Pages 392-395 2.3.3.29. Author(s): B Quinn, C.M.J. Potting, R Stone, N.M.A. Blijlevens, M Fliedner, A Margulies, L SharpTitle: Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients Source: Eur J Cancer. 2007 doi: 10.1016 / j.ejca. 2007. 09. 014 2.3.3.30. Author(s): MC Guedes; R Weber; MVS Gomez; RB Neto; CG Peralta; RF Bento Title: Influence of evoked compound action potential on speech perception in cochlear implant users Source: Rev. Bras. Otorrinolaringol. vol.73 no.4 São Paulo July/Aug. 2007 19
2.3.3.31. Author(s): AP Chaves; JAP Gomes; ALH Lima Title: Ocular changes induced by chemotherapy Source: Arq Bras Oftalmol. 2007;70(4):718-25 2.3.3.32. Author(s): Debra J Harris Title: Cancer treatment-induced mucositis pain: strategies for assessment and management Source: Dove Medical Press, Sepp 2006, Vol 2, Iss 3, Page 251-258 2.3.3.33. Author(s): J. M. Blazeby, C. Metcalfe, J. Nicklin, C. P. Barham, J. Donovan, D. Alderson Title: Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia Source: British Journal of Surgery, 2005 Volume 92, Issue 12, Pages 1502 1507 2.3.3.34. Author(s): Y. Dan, J. So, K. Yeoh Title: Endoscopic Screening for Gastric Cancer. Source: Clinical Gastroenterology and Hepatology, Volume 4, Issue 6, Pages 709-716 2.3.3.35. Author(s): Bonnetain F, Bouche O, Conroy T, Arveux P, Raoul JL, Giovanni M, Etienne PL, Mitry E, Seitz JF, Rougier P, Gırault C, Bedenne L, Title: Longitudinal quality of life study in patients with metastatic gastric cancer. Source: Gastroenterol Clin Biol 2005;29:1113-1124 2.3.3.36. Author(s): Scurtu R, Groza N, Otel O, Goia A, Funariu G Title: Quality of Life in Patients with Esophagojejunal Anastomosis after total Gastrectomy for Cancer. Source: Rom J Gastroenterol 2005, Vol 14. No 4, 367-372 2.3.3.37. Author(s): Sadighi S, Hohagheghi MA, Montazeri A, Sadighi Z Title: Quality of life in patients with advanced gastric cancer: a randomizad trial comparing Docetaxel Cisplatin 5-FU (TCF) with Epirubicin Cisplatin 5-FU (ECF). Source: BMC Cancer 2006; 1471/2407/6/274 2.3.3.38. Author(s): Olivier B Title: Comment am liorer le pronostic du cancer gastrique en France? Source: Gastroenterol Clin Biol 2005;29:7-10 2.3.3.39. Author(s): P. Costa, J. Carraca, A. Sofia Brito, N. Figueiredo, P. Lages Title: Avaliação multifactorial da qualidade de vida em doentes gastrectomizados por cancro gástrico. estudo piloto de métodos de avaliação Source: J Port Gastrenterol 2006, 13:174-180 2.3.3.40. Author(s): Satoshi M, Adrian AK, Akira T, Yasuhiro K, Takanori M, Junichi S Title: Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Source: Gastric Cancer 2006, Vol 9, No 4, 254-261 2.3.3.41. Author(s): T Conroy, F Marchal, JM. Blazeby Title: Quality of Life in Patients with Oesophageal and Gastric Cancer: An Overview Source: Oncology 2006;70:391-402, 2.3.3.42. Author(s): CC Huang, HH Lien, YC Sung, HT Liu, WC Chie Title: Quality of life of patients with gastric cancer in Taiwan: validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22 Source: Psycho-Oncology, Volume 16, Issue 10, Pages 945 949 2.3.3.43. Author(s): JM Bae, S Kim, YW Kim, KW Ryu, JH Lee, JH Noh, TS Sohn, SK Hong, SM Park, CH You, JH Kim, MK Lee, YH Yun Title: Health-related quality of life among disease-free stomach cancer survivors in Korea Source: Quality of Life Research, 2006, Vol 15 No: 10 / 1587-1596 20
2.3.3.44. Author(s): P. Lagergren, P. Fayers, T. Conroy, H. Stein, O. Sezer, R. Hardwick, E. Hammerlid, A. Bottomley, E. Van Cutsem, J. Blazeby Title: Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago gastric junction and the stomach. Source: European Journal of Cancer, Volume 43, Issue 14, Pages 2066-2073 2.3.3.45. Author(s): Y. Yun, S. Kim, K. Lee, S. Park, Y. Kim Title: Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations Source: Journal of Clinical Epidemiology, Volume 60, Issue 11, Pages 1164-1175 2.3.3.46. Author(s): R Pai, C Lin, T Tran, A Tarnawski Title: Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation Source: Biochemical and Biophysical Research Communications 2005, Vol 331, Iss 4, 17, Pages 984-992 2.3.3.47. Author(s): I Wolf, S Sadetzki, H Kanety, Y Kundel, C Pariente, N Epstein, B Oberman, R Catane, B Kaufman, I Shimon, Title: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients Source: Cancer, 2006, Vol 106, Iss 4, Pages 966-973 2.3.3.48. Author(s): Dai Shida, Joji Kitayama, Ken Mori, Toshiaki Watanabe and Hirokazu Nagawa Title: Transactivation of Epidermal Growth Factor Receptor Is Involved in Leptin-Induced Activation of Janus-Activated Kinase 2 and Extracellular Signal Regulated Kinase 1/2 in Human Gastric Cancer Cells Source: Cancer Research 65, 9159-9163, October 15, 2005 2.3.3.49. Author(s): M Koda, M Sulkowska, LK Koda, E Surmacz, S Sulkowski, Title: Overexpression of the obesity hormone leptin in human colorectal cancer Source: Journal of Clinical Pathology 2007;60:902-906 2.3.3.50. Author(s): ER Ropelle, JR Pauli, KG Zecchin, M Ueno, CT Souza, J Morari, MC Faria, LA Velloso, MJA Saad, JBC Carvalheire Title: A Central Role For Neuronal Amp Actıvated Proteın Kınase (Ampk) In Cancer-Induced Anorexıa Source: Endocrinology 2007, Vol. 148, No. 11 5220-5229 2.3.3.51. Author(s): Douglas A Corley Title: Obesity and the rising incidence of oesophageal and gastric adenocarcinoma Source: Gut 2007;56:1493-1494 2.3.3.52. Author(s): M Koda, M Sulkowska, L Kanczuga-Koda, S Cascio, G Colucci, A Russo, E Surmacz, S Sulkowski Title: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 in human colorectal cancer Source: Annals of Oncology 2007 18(Supplement 6):vi116-vi119 2.3.3.53. Author(s): Petersen SL; Wagner A; Gimsing P. Title: Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Source: AMERICAN JOURNAL OF HEMATOLOGY 1999, Vol 62, Iss 4, pp 228-233. 2.3.3.54. Author(s): Wellwood J; Taylor K; Wright S; Bentley M; Hill G; Phan H; Norris D; Livsey R. Title: Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis. Source: LEUKEMIA & LYMPHOMA 2002, Vol 43, Iss 4, pp 893-896 21
2.3.3.55. Author(s): Hayes-Lattin B; Blanke CD; Deloughery TG. Title: Pulmonary and intracerebral plasmacytomas in a patient without multiple myeloma: A case report. Source: AMERICAN JOURNAL OF HEMATOLOGY 2003, Vol 73, Iss 2, pp 131-134 2.3.3.56. Author(s): C Pontikoglou; C Fragos; E Kolyvaki; G Samonis a ; GD Eliopoulos; HA.Papadaki. Title: Multiple myeloma involving the central nervous system: a report of two cases with unusual manifestations Source: Leukemia and Lymphoma, Volume 46, Issue 5 May 2005, pages 737 741 2.3.3.57. Author(s): JT Rosal, I Aleman, J Ronquillo, I Puerto, L Rodriguez Title: Glioblastoma multiforme arising in the setting of multiple myeloma Source: Haema 2005; 8(4):704-706 2.3.3.58. Author(s): Asherson RA; Cervera R. Title: Antiphospholipid antibodies and infections. Source: ANNALS OF THE RHEUMATIC DISEASES 2003, Vol 62, Iss 5, pp 388-393 2.3.3.59. Author(s): Cervera R; Asherson RA; Acevedo ML; Gomez-Puerta JA; Espinosa G; de la Red G; Gil V; Ramos-Casals M; Garcia-Carrasco M; Ingelmo M; Font J. Title: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Source: ANNALS OF THE RHEUMATIC DISEASES 2004, Vol 63, Iss 10, pp 1312-1317. 2.3.3.60. Author(s): Ramos-Casals M; Cervera R; Lagrutta M; Medina F; Garcia- Carrasco M; de la Red G; Bove A; Ingelmo M; Font J. Title: Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/hiv infection): Description of 82 cases. Source: CLINICAL INFECTIOUS DISEASES 2004, Vol 38, Iss 7, pp 1009-1016 2.3.3.61. Author(s): Asherson RA; Shoenfeld Y. Title: Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. Source: JOURNAL OF RHEUMATOLOGY 2003, Vol 30, Iss 2, pp 214-219 2.3.3.62. Author(s): P Hopwood Title: Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer Source: Current Opinion in Oncology. July 2005, 17(4):340-344, 2.3.3.63. Author(s): A MacArthur, CD Bajdik, JJ Spinelli, C Kim-Sing, RP Gallagher Title: Predicting interest in genetic counseling and testing for cancer susceptibility: The British Columbia Family Cancer Survey Pilot Study Source: BC Medical Journal Volume 48, Number 5, June 2006, page 222-225 2.3.3.64. Author(s): U. Gallkowski, H Muller, S. Manekeller, J. Boese-Landgraf, S. Ridwelski Title: Umgang und Pflege implantierter Portkathetern bei Tumorpatiaenten ein interdisziplinres Problem Source: Surgical Oncology 2.3.3.65. Author(s): ÖU Yesilbalkan Title: Onkoloji Hastalarında Sık Kullanılan Venöz Giriş Aracı: İmplante Port Kateter Source: C.Ü. Hemşirelik Yüksek Okulu Dergisi 2005, 9 (2) 2.3.3.66. Author(s): KW Jauch, W Schregel, Z Stanga Title: 9 Technik und Probleme der Zugange in der parenteralen Ernahrung Source: Aktuel Ernaehr Med 2007; 32, Supplement 1: S41-S53 2.3.3.67. Author(s): N. Villanueva; E. Esteban; I. Muñiz J. Vieitez I L. Olay; I. Jimenez; P. Jimenez; M. Luque; B. Llorente; M. Capelan; E. Estrada; Y. Fernández; J. Fra; A. J. Lacave Title: Radioterapia torácica con 70 Gy concurrente con docetaxel o paclitaxel 22
semanal tras quimioterapia de inducción en pacientes con carcinoma de pulmón no microcítico localmente avanzado. Estudio prospectivo de tolerancia y eficacia Source: Oncología (Barc.) v.29 n.10 Madrid dic. 2006 2.3.3.68. Author(s): EE Vokes, J. E. Herndon, M. J. Kelley, D. Watson, M. G. Cicchetti, M. R. Gren Title: Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial Source: Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7005 2.3.3.69. Author(s): YS Gouda, HM Kohail, NA Elddeb, AM Omar, MM El-Geneidy, YM Elkerm Title: Randomized Study of Concurrent Carboplatin, Paclitaxel, and Radiotherapy Induction Chemotherapy in Patients with Locally Advanced Non Small cell lung cancer Source: Journal of the Egyptian Nat. Cancer Inst. March 2006, Vol 18, No 1, 73-81 2.3.3.70. Author(s): Rossi P; Di Lorenzo G; Formisano R; Buzzi MG. Title: Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients. Source: HEADACHE 2004, Vol 44, Iss 7, pp 713-718 2.3.3.71. Author(s): K. Paemeleire, A. Bahra, S. Evers, MS Matharu, PJ Goadsby, Title: Medication-overuse headache in patients with cluster headache Source: NEUROLOGY 2006;67:109-113 2.3.3.72. Author(s): S Sitalakshmi, R Karuna, D Prema Title: Do plasma D-dimer levels correlate with disease stage in colonic carcinoma? Source: Indian Journal of Surgery, 2006, Vol 68, Iss 6, Page 306-309 2.3.3.73. Author(s): JIN Xiao-shi Title: The research on the changes of the D-dimer and fibrinogen concentrations in the patients with colorectal carcinoma Source: Journal of Tianjin Medical University 2006, VoI.12.No.3 Sep.404-405 2.3.3.74. Author(s): E Renoult, C Buteau, V Lamarre, N Turgeon, B Tapiero Title: Infectious risk in pediatric organ transplant recipients: Is it increased with the new immunosuppressive agents? Source: Pediatric Transplantation 2005, 9 (4), 470 479 2.3.3.75. Author(s): Wang HX, Jı SQ, Zhu L, Lıu J, Xue M, Dıng L, Duan LN, Yan HM, Chen HR Title: Neurological Complications Following Haploidentical Bone Marrow Transplantation Source: Journal of Experimental Hematology 2005, Vol 13, No 6, 1128-1130 2.3.3.76. Author(s): Atesci FC; Baltalarli B; Oguzhanoglu NK; Karadag F; Ozdel O; Karagoz N. Title: Psychiatric morbidity among cancer patients and awareness of illness. Source: SUPPORTIVE CARE IN CANCER 2004, Vol 12, Iss 3, pp 161-167 2.3.3.77. Author(s): Mehta VK, Poen J, Ford J, Oberhelman H, Vierra MA, Bastidas AJ, Fisher GA. Title: Protracted Venous Infusion 5-Fluorouracil With Concomitant Radiotherapy Compared With Bolus 5-Fluorouracil for Unresectable Pancreatic Cancer Source: American Journal of Clinical Oncology. 2001, 24(2):155-159, 2.3.3.78. Author(s): R Wilkowski, M Wolf, V Heinemann Title: Primary Advanced Unresectable Pancreatic Cancer Source: Pancreatic Cancer, 2007, Vol 177, Iss 80-15, Pages 79-93 23